Studies have found that the expression level of MBLs protein in the cerebrospinal fluid of AD patients is significantly reduced (Moller-Kristensen et al., 2006), and the expression level of the anti-inflammatory factor Fetuin-A in the plasma of patients with mild to moderate AD is also significantly reduced (Smith et al., 2011). Here, AHSG is linked to Alzheimer disease.